Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer (Q28364208)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

Bottini A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Berruti A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Bersiga A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Brizzi MP

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Aguggini S

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Brunelli A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Bolsi G

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Allevi G

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Generali D

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Betri E

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Bertoli G

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Alquati P

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Dogliotti L

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

language of work or name

English

0 references

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

1106-1112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

3 December 2019

copyright license

start time

1 October 2001

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375158

The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375158

HER-2/neu as a predictive marker of response to breast cancer therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375158

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375158

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375158

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375158

p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients

2 June 2018

1 reference

12 December 2020

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies

1 reference

12 December 2020

Changes in cell kinetics induced by primary chemotherapy in breast cancer

1 reference

12 December 2020

Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up

1 reference

12 December 2020

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

12 December 2020

Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy

1 reference

12 December 2020

Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer

1 reference

12 December 2020

Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer

1 reference

12 December 2020

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

12 December 2020

Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer

1 reference

12 December 2020

Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma

1 reference

12 December 2020

bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study

1 reference

12 December 2020

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

12 December 2020

Changes of biological features in breast cancer cells determined by primary chemotherapy

1 reference

12 December 2020

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

12 December 2020

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

12 December 2020

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

1 reference

12 December 2020

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer

1 reference

12 December 2020

Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2001.2048

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

3 December 2019

1030641933

0 references

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11710821%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

PubMed publication ID

11710821

2 references